Story · Medicine & Biotech
Aakash Desai: What a US Real-World Study Says About Outcomes in HER2-Mutant NSCLC
1 outlet · first reported by OncoDaily on
Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on LinkedIn: “HER2-mutant NSCLC has carried a poor prognosis with limited options. A US clinico-genomic study in Lung Cancer sets (OncoDaily)
Coverage, in order
-
Aakash Desai: What a US Real-World Study Says About Outcomes in HER2-Mutant NSCLCAakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on LinkedIn: “HER2-mutant NSCLC has carried a poor prognosis with limited options. A US clinico-genomic study in Lung Cancer sets
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.